R. Keith Campbell, Professor, B.Pharm, MBA, CDE, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.

Home / R. Keith Campbell, Professor, B.Pharm, MBA, CDE (page 2)

R. Keith Campbell, Professor, B.Pharm, MBA, CDE

The late R. Keith Campbell was an Associate Dean and later the Distinguished Professor in Diabetes Care/Pharmacotherapy at the Washington State University College of Pharmacy in Pullman, Washington. He was a member of the faculty from 1968 until his death. Keith was distinguished as being one of the first pharmacists to become a CDE (Certified Diabetes Educator) and encouraged 100’s of pharmacists to become certified as CDE’s. Keith truly changed the way pharmacists practice pharmacy. He was an active diabetes educator and involved in numerous diabetes-related activities. He was the Chair of the Medical Advisory Board for the Washington State Diabetes Control Project funded by the Center for Disease Control. He served on numerous committees for the American Diabetes Association, the American Association of Diabetes Educators, and the NIH. He was a member of professional panels that wrote the position statements on Blood Glucose Monitoring for both ADA and AADE and assisted the NIH in translating the famous Diabetes Control and Complications Trial to try to change the treatment objectives of diabetes patients. He had a personal interest in diabetes having lived with Type 1 diabetes for over 61 years. He used an insulin pump for over 32 years.

Keith Campbell, Part 2: Advice for Healthcare Providers

Oct 5, 2015 Exclusive Interviews 3,141 views

This week, Associate Medical Editor Joy Pape continues her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he shares his advice with other healthcare providers in regards to how to help their patients. He advocates for patient education now to mitigate the expensive complications that could happen later.

Afrezza: Treating Diabetes in a Physiologic Manner

Jul 18, 2014 Featured Writers, Prediabetes, Sulfonylurea 7,569 views

R. Keith Campbell, RPh, FAADE, FASHP, FAPhA, CDE, Distinguished Professor Emeritus in Diabetes Care/Pharmacotherapy, Washington State University College of Pharmacy The health care crisis created by the explosion of diabetes worldwide is one of society’s greatest challenges. The IDF projects that the prevalence of diabetes by 2030 will be over 550 …

ADA/PDR: Medications for the Treatment of Diabetes, Ch. 18, Pt. 3

Mar 11, 2011 Clinical Gems 3,025 views

Diabetic Neuropathic Disorders, Part 3 John R. White, Jr., PharmD, PA R. Keith Campbell, PharmB, MBA, CDE Travis E. Sonnett, PharmD Adaptation by Matthew Szabo, PharmD (candidate) This week we conclude our three-part excerpt of the ADA/PDR text chapter on Neuropathic Disorders….

ADA/PDR: Medications for the Treatment of Diabetes, Ch. 18, Pt. 2

Mar 5, 2011 Clinical Gems 2,620 views

Diabetic Neuropathic Disorders, Part 2 John R. White, Jr., PharmD, PA R. Keith Campbell, PharmB, MBA, CDE Travis E. Sonnett, PharmD Adaptation by Matthew Szabo, PharmD (candidate) Diabetic Gastroparesis Treatment Options This week we continue our exploration of diabetic neuropathic disorders with analyses of two drugs used to treat diabetic …

ADA/PDR: Medications for the Treatment of Diabetes, Ch. 18, Pt. 1

Feb 26, 2011 Clinical Gems 2,565 views

Diabetic Neuropathic Disorders John R. White, Jr., PharmD, PA R. Keith Campbell, PharmB, MBA, CDE Travis E. Sonnett, PharmD Adaptation by Matthew Szabo, PharmD (candidate) Overview The two most common forms of neuropathy that affect diabetes patients are diabetic peripheral neuropathy (DPN) and diabetic autonomic neuropathy (DAN).

Page 2 of 2«12